Mach-1 Financial Group’s AbbVie ABBV Stock Holding History

Mach-1 Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,029	Closed	-$659K	–	132
2026 Q1	$659K	Sell	3,029 -6,005	-66%	-$1.33M	0.23%	60
2025 Q4	$2.06M	Buy	9,034 +5,809	+180%	+$1.32M	0.42%	48
2025 Q3	$747K	Sell	3,225 -5,801	-64%	-$1.18M	0.12%	91
2025 Q2	$1.68M	Sell	9,026 -410	-4%	-$76.2K	0.49%	50
2025 Q1	$1.98M	Buy	+9,436	New	+$1.83M	0.59%	38
2024 Q4	–	Sell	-1,079	Closed	-$213K	–	58
2024 Q3	$213K	Sell	1,079 -164	-13%	-$30.6K	0.13%	83
2024 Q2	$213K	Sell	1,243 -241	-16%	-$39.9K	0.14%	67
2024 Q1	$270K	Sell	1,484 -17,314	-92%	-$2.98M	0.21%	49
2023 Q4	$2.91M	Buy	18,798 +4,187	+29%	+$610K	1.1%	23
2023 Q3	$2.18M	Buy	14,611 +84	+0.6%	+$12.3K	0.9%	23
2023 Q2	$1.96M	Buy	14,527 +13,789	+1,868%	+$2.02M	0.55%	43
2023 Q1	$118K	Sell	738 -10,704	-94%	-$1.64M	0.75%	40
2022 Q4	$1.85M	Buy	11,442 +10,471	+1,078%	+$1.61M	0.61%	25
2022 Q3	$130K	Buy	971 +40	+4%	+$5.74K	0.14%	60
2022 Q2	$142K	Buy	+931	New	+$142K	0.1%	61
2022 Q1	–	Sell	-18	Closed	-$2K	–	201
2021 Q4	$2K	Buy	+18	New	+$2.13K	﹤0.01%	189

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mach-1 Financial Group's ABBV Position: Q2 2026 in Review

Mach-1 Financial Group sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 3,029 shares — an estimated $659K sold.

Mach-1 Financial Group first reported a position in ABBV in Q4 2021 and held it in 16 quarters. The position peaked at $2.91M in Q4 2023. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mach-1 Financial Group reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Mach-1 Financial Group sold 3,029 AbbVie shares in Q2 2026, an estimated $659K.
Mach-1 Financial Group first reported a position in AbbVie in Q4 2021 and held it in 16 quarters.
Mach-1 Financial Group's AbbVie position peaked at $2.91M in Q4 2023.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mach-1 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.